Trulicity ® (dulaglutide)

This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. Please refer to the link for full prescribing information: Trulicity Summary of Product Characteristics (SmPC)

Trulicity® (dulaglutide): How do you treat an overdose?

Supportive care should be initiated based on signs/symptoms in the event of dulaglutide overdose.

Effects of Dulaglutide Overdose

Overdoses of dulaglutide have been reported in clinical studies.1

Effects of overdose with dulaglutide in clinical studies have included gastrointestinal disorders and hypoglycaemia.2

In the event of overdose, appropriate supportive treatment should be initiated according to the patient’s clinical signs and symptoms. 2

References

1. Data on file, Eli Lilly and Company and/or one of its subsidiaries.

2. Trulicity [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.

Date of Last Review: July 07, 2020


Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com

Available Mon - Fri, 10am - 4pm, excluding Bank Holidays

Or you can

Chat with Us

Click to Chat is Offline

If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a request